“There is a real cost to moving fast”: Using AI to accelerate drug discovery
On this episode of Leaders of Code, Ben Popper hosts a conversation with Maureen Makes, VP of Engineering at Recursion, and Ellen Brandenberger, Senior Director of Product Strategy for Overflow API. They discuss AI's role in drug discovery, scaling and integration challenges, and the importance of innovation in achieving the high standards desired.
